Well-being

Wellbeing Digital to Participate in the Psychedelic Medicine Association Webinar

Retrieved on: 
Wednesday, January 25, 2023
Other Health, Research, General Health, Professional Services, Mental Health, Small Business, Science, Biotechnology, Alternative Medicine, Finance, Other Science, Health, Therapy, PMA, Najla, MEDI, FRA, NEO, SQ2, Well-being, OTC, Pharmaceutical industry

Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that Najla Guthrie, CEO of Wellbeing, will participate at the upcoming Psychedelic Medicine Association (PMA) Webinar on Thursday, January 26th at 5 pm Pacific, 8 pm Eastern.

Key Points: 
  • Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that Najla Guthrie, CEO of Wellbeing, will participate at the upcoming Psychedelic Medicine Association (PMA) Webinar on Thursday, January 26th at 5 pm Pacific, 8 pm Eastern.
  • Najla will participate on “Increasing Access to Psychedelic Medicines and Therapies,” panel on January 26th at 5 pm PST/8pm EST.
  • For more information about the webinar, or to schedule a one-on-one meeting with Wellbeing management team, please send an email to Natalie Dolphin at [email protected] .

Lü and Megaform Expand Their Educational Offering With the Acquisition of Marbotic

Retrieved on: 
Thursday, January 26, 2023
Well, Education, Light, Catalog, School, Heart, Love, Acquisition, Reading, Frasier, Osmo, Physical education, Learning, Well-being, Toy, Quebec City, Marcellin Marbot, Apple Store, Montessori education

QUEBEC CITY, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Lü Interactive Playground and Megaform are proud to announce the joint acquisition of Marbotic , a French educational technology company.

Key Points: 
  • QUEBEC CITY, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Lü Interactive Playground and Megaform are proud to announce the joint acquisition of Marbotic , a French educational technology company.
  • I knew we had to make sure that such a great educational tool would stand the test of time,” said Vincent Routhier, CEO of Lü Interactive Playground.
  • At Megaform, education is at the heart of our mission, so it made perfect sense to partner with Lü to acquire Marbotic,” added Christian Pirali, CEO of Megaform.
  • Lü and Megaform would like to thank the communities, loyal clients, and partners who have supported Marbotic since its very beginning.

Wellbeing Digital Announces Change of Auditor

Retrieved on: 
Wednesday, January 18, 2023
Biotechnology, Health, Mental Health, Other Health, SQ2, Disagreement, OTC, Well-being, NEO, FRA, NI, MEDI, Auditor, Therapy, SEDAR, National instrument, Audit

Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, today announces that is has changed its auditors.

Key Points: 
  • Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, today announces that is has changed its auditors.
  • At the request of the Company, Macias Gini & O’Connell LLP (“Former Auditor”) resigned as the auditor of the company and the board of directors of the Company appointed Mao & Ying LLP (“Successor Auditor” or “Mao”) effective January 13, 2023.
  • There were no reservations or modified opinions in the Former Auditor's reports on the Company's financial statements during the period that the Former Auditor acted as the Company's auditor.
  • In accordance with NI 51-102, the notice of change of auditor, together with the required letters from the Former Auditor and the Successor Auditor, have been reviewed by the board of directors of the Company and filed on SEDAR.

Wellbeing Subsidiary KGK Science Receives Approval for First-of-its-Kind Psylocibin Clinical Trial

Retrieved on: 
Thursday, December 22, 2022
Mental Health, Health, General Health, Clinical Trials, Research, Science, Biotechnology, MEDI, Clinical trial, NOVA, KGK, Autism, Fragile X syndrome, Research, Health Canada, Phase II, NEO, Trial of the century, CSE, Science, SQ2, Psilocybin, ASD, OTC, CGMP, Nova, Therapy, Well-being, FXS, FRA, Pharmaceutical industry

“Our team at KGK has successfully helped hundreds of companies with custom designed clinical trials and claim substantiation strategies that move products efficiently into the global markets over the past 25 years.

Key Points: 
  • “Our team at KGK has successfully helped hundreds of companies with custom designed clinical trials and claim substantiation strategies that move products efficiently into the global markets over the past 25 years.
  • We are thrilled to receive approval for this pioneering Phase II A psilocybin clinical study for our client Nova Mentis,” commented Najla Guthrie, CEO of Wellbeing and KGK.
  • The trial will be led by KGK Science and recruiting efforts are expected to begin in early 2023.
  • “We are thrilled to receive Health Canada approval for our pioneering psilocybin study.

Fujitsu Joins Scholarship Partner Program of Kamiyama Marugoto College of Design, Engineering and Entrepreneurship, Contributes One Billion Yen to Scholarship Fund

Retrieved on: 
Monday, December 12, 2022
School, Human rights, GRB, Student, Challenge, Indian Institute of Information Technology, Design and Manufacturing, Jabalpur, US, Well-being, Equity, Occupational safety and health, Social responsibility, Environment, Education, Convergence of random variables, Inclusion, Tokenization (data security), Supply chain, Growth, Being Globally Responsible Conference, Security, AI, Tutoring, Management, Fujitsu, Engineering, Entrepreneurship, Safety

Fujitsu contributed one billion yen to the scholarship fund for the school.

Key Points: 
  • Fujitsu contributed one billion yen to the scholarship fund for the school.
  • Kamiyama Marugoto College will combine the three pillars of Technology, Design, and Entrepreneurship, with the aim to foster talented people who will change the future and contribute to solving social issues.
  • Fujitsu decided to contribute to the scholarship partner program as Kamiyama Marugoto College's concept matches with Fujitsu's purpose, "to make the world more sustainable by building trust in society through innovation", and its community initiatives under its GRB (Global Responsible Business)(3) goals.
  • Program launched in November 2021 under the motto "Fujitsu: Challenge is the norm" to develop intrapreneurs and create new businesses.

Signia Supports Veterans and Active Military Members with $25,000 Donation Match Day to Benefit Fisher House Foundation

Retrieved on: 
Tuesday, December 6, 2022
Audiology, Native Americans, Well-being, Freedom, Transport, Veteran, United States Department of Defense, Fisher House, U.S. Department of Veterans Affairs, Office of Inspector General, Health care, VA, IHS, Fisher House Foundation, Kool-Aid, Hearing loss, U.S. Department of Defense Strategy for Operating in Cyberspace, Woman, Indian Health Service, Quality of life, Bath, Hearing, Health, House Foundation, Medical device, Hospital, Pharmaceutical industry, Signia

PISCATAWAY, N.J., Dec. 6, 2022 /PRNewswire/ -- Reaffirming its commitment to delivering unparalleled support to veterans and active military members, hearing aid innovator Signia announced today it will match up to $25,000 in donations on December 30, 2022, to benefit Fisher House Foundation. If the goal is reached, the foundation will receive a total of $50,000 to aid its mission of building homes near military and VA medical facilities to offer free, convenient and comfortable accommodations for military families while a loved one receives care.

Key Points: 
  • PISCATAWAY, N.J., Dec. 6, 2022 /PRNewswire/ -- Reaffirming its commitment to delivering unparalleled support to veterans and active military members, hearing aid innovator Signia announced today it will match up to $25,000 in donations on December 30, 2022, to benefit Fisher House Foundation .
  • "At Signia, we understand that many of our veterans and active military members require and deserve medical treatment related to their service," Murray said.
  • "By supporting the mission of Fisher House Foundation, we aim to help to make the lives of veterans, service members and their families easier when they need care.
  • "Fisher House Foundation is grateful for Signia's matching gift on December 30 that doubles the impact for our generous donors," said Ken Fisher, Chairman and CEO of Fisher House Foundation.

Wellbeing Subsidiary Mindscape Treats its 1,000th Patient

Retrieved on: 
Tuesday, November 29, 2022
Alternative Medicine, Mental Health, Health, Other Health, Clinical Trials, Biotechnology, Mental health, NEO, Well-being, OTC, SQ2, Bipolar disorder, Clinic, Life, Emergency physician, Chronic pain, Patient, Anxiety, Drug development, Depression, Ketamine, PLLC, Mindscape, Digital Science, Therapy, PTSD, Infusion therapy, IV, OCD, MEDI, FRA, Acquisition, Pharmaceutical industry

Today, Mindscape aims to help facilitate patient healing using low-dose IV ketamine treatments.

Key Points: 
  • Today, Mindscape aims to help facilitate patient healing using low-dose IV ketamine treatments.
  • The Clinic reached the patient milestone in less than two years since its acquisition by Wellbeing, demonstrating the great need for this breakthrough treatment.
  • "In addition to the Clinics remarkable efficiency and reduction in treatment times, the clinical advantages of IV Ketamine therapy have also become increasingly evident, said Najla Guthrie, CEO of Wellbeing Digital Sciences.
  • Subsidiary of Wellbeing Digital Sciences, Mindscape Ketamine & Infusions Therapy, PLLC is a clinic in Houston, Texas, offering affordable delivery of concierge IV ketamine therapy for treatment-resistant mood disorders, mental health disorders, and chronic pain conditions.

Galexxy Holdings Inc., Announces its Intention to Pursue Dual Listing on the Upstream Platform

Retrieved on: 
Wednesday, November 16, 2022
Ethereum, Well-being, OTC, Initial public offering, World Federation of Exchanges, U.S. International Development Finance Corporation, World government, White label, Non-fungible token, OTC Markets Group, Acquisition, Security (finance), Upstream

Newport Beach, CALIFORNIA, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Galexxy Holdings Inc., (Galexxy or Company) (OTC: GXXY) announced today that following a recent board meeting, the directors of the Company authorized management to pursue a dual listing on Upstream.

Key Points: 
  • Newport Beach, CALIFORNIA, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Galexxy Holdings Inc., (Galexxy or Company) (OTC: GXXY) announced today that following a recent board meeting, the directors of the Company authorized management to pursue a dual listing on Upstream.
  • Upstream is an exciting new digital exchange that offers up and coming companies access to global investors.
  • Upstream is a MERJ Exchange Market and an affiliate of the World Federation of Exchanges.
  • Upstream offers global investors direct access to US equities through a real-time, secure, and intuitive trading app.

Wellbeing Digital Announces the Appointment of Mohammad Sharifi to Board of Directors

Retrieved on: 
Tuesday, November 22, 2022
Research, General Health, Professional Services, Pharmaceutical, Mental Health, Small Business, Science, Biotechnology, Alternative Medicine, Finance, Other Science, Health, Marketing, OTC, Audit committee, Drug development, Housing, Communities and Local Government Committee, FRA, Well-being, Research, SQ2, MEDI, Mental health, Therapy, Growth, Education, NEO, Patient, Knowledge, Pharmaceutical industry

Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces the appointment of Mohammad Sharifi to the Wellbeing Board of Directors (the Board), effective November 22, 2022.

Key Points: 
  • Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces the appointment of Mohammad Sharifi to the Wellbeing Board of Directors (the Board), effective November 22, 2022.
  • Mr. Mohammad Sharifi will serve as a member of the Audit Committee and Governance Committee of the Board.
  • We are pleased to welcome Mohammad to the Board, said Najla Guthrie, CEO of Wellbeing.
  • Mr. Sharifi has extensive experience in marketing and digital communications which has spanned across the consumer products industry.

Wellbeing Digital Announces Resignation of Directors

Retrieved on: 
Friday, November 18, 2022
Research, Mental Health, Finance, Professional Services, Small Business, Biotechnology, General Health, Health, Science, Other Science, OTC, Drug development, FRA, Najla, Well-being, SQ2, MEDI, Therapy, Growth, NEO, Patient, Pharmaceutical industry, Management

Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that James Henning and Steven Inglefield have stepped down as directors of the Company.

Key Points: 
  • Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that James Henning and Steven Inglefield have stepped down as directors of the Company.
  • James has served on the Wellbeing board of directors since the Companys inception, said Najla Guthrie, CEO of Wellbeing.
  • With the Companys decision to divest IRP Health Ltd. (IRP), Steven leaves to focus on IRPs expanding growth.
  • Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company focused on the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research.